7151 - 7200 of 8808 Results
Title
Year
-
OPENTitle: Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease PatientJournal Name: CellsPublisher: MDPI AGVol: 12Issue #: 4Start Page: 625End Page: 625Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells12040625Best OA location URL: https://www.mdpi.com/2073-4409/12/4/625/pdf?version=1676960152Citation Count: 31
-
OPENTitle: Decreased SNCA expression in whole-blood RNA analysis of Parkinson’s disease adjusting for neutrophilsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-01062-4Best OA location URL: https://www.nature.com/articles/s41531-025-01062-4.pdfCitation Count: 0
-
OPENTitle: Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1Journal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 581End Page: 594Publication Date:Open Access(OA) Status: OPENLicense: unspecified-oaDOI - Digital Object Identifier: 10.3233/jpd-150570Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150570?id=journal-of-parkinsons-disease%2Fjpd150570Citation Count: 29
-
RESTRICTEDTitle: Cognitive Predictors of Responsiveness to Reactive Step Training in People with Parkinson’s Disease at Fall-RiskJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 817Issue #:Start Page: 137517End Page: 137517Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2023.137517Citation Count: 2
-
RESTRICTEDTitle: Heartbeat signature for predicting motor and non-motor involvement among nonparkinsonian LRRK2 G2019S mutation carriersJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 35Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10286-024-01104-6Citation Count: 0
-
RESTRICTEDTitle: Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted ratsJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 219Issue #: 1Start Page: 355End Page: 358Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2009.04.010Citation Count: 46
-
OPENTitle: Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MSJournal Name: Clinical BiochemistryPublisher: Elsevier BVVol: 72Issue #:Start Page: 7End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clinbiochem.2019.05.006Best OA location URL: https://doi.org/10.1016/j.clinbiochem.2019.05.006Citation Count: 34
-
OPENTitle: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 52
- TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson’s Disease2020OPENTitle: TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson’s DiseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 33Issue #: 9Start Page: 108418End Page: 108418Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2020.108418Best OA location URL: http://www.cell.com/article/S2211124720314078/pdfCitation Count: 60
-
RESTRICTEDTitle: Clinical and imaging markers in premotor LRRK2 G2019S mutation carriersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 10Start Page: 1170End Page: 1176Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.007Citation Count: 37
-
RESTRICTEDTitle: Vocal tics in Tourette's syndromeJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 15Issue #: 3Start Page: e1End Page: e1Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(16)00021-1Citation Count: 4
-
OPENTitle: Missing Drivers with Dementia: Antecedents and RecoveryJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 60Issue #: 11Start Page: 2063End Page: 2069Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1111/j.1532-5415.2012.04159.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1532-5415.2012.04159.xCitation Count: 20
-
OPENTitle: The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 13Issue #: 9Start Page: 1303End Page: 1303Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom13091303Best OA location URL: https://www.mdpi.com/2218-273X/13/9/1303/pdf?version=1692936929Citation Count: 0
-
OPENTitle: α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic NeurodegenerationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 105Issue #:Start Page: 84End Page: 98Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.05.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5701756Citation Count: 154
-
OPENTitle: Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative CohortJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 1Start Page: 47End Page: 53Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12553Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5898442Citation Count: 162
-
OPENTitle: How Parkinson’s patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide surveyJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 95Issue #:Start Page: 20End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2021.11.017Best OA location URL: https://scholarsphere.psu.edu/resources/29554bfc-5d79-4aa6-b1c5-e9441fea8e4aCitation Count: 8
-
RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
-
RESTRICTEDTitle: Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+ and Imaging of Zn2+-induced Fe2+ Flux in Living Cells and Elevated Fe2+ in Ischemic StrokeJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 27Issue #: 2Start Page: 302End Page: 308Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.5b00259Citation Count: 70
- Deep brain stimulation has state-dependent effects on motor connectivity in Parkinson’s disease2019OPENTitle: Deep brain stimulation has state-dependent effects on motor connectivity in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 8Start Page: 2417End Page: 2431Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz164Best OA location URL: https://academic.oup.com/brain/article-pdf/142/8/2417/32742258/awz164.pdfCitation Count: 51
-
OPENTitle: The End Is the Beginning: Parkinson’s Disease in the Light of Brain ImagingJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00330Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2017.00330/pdfCitation Count: 34
-
OPENTitle: Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative DiseasesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 4Start Page: 2364End Page: 2364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25042364Best OA location URL: https://www.mdpi.com/1422-0067/25/4/2364/pdf?version=1708157539Citation Count: 3
-
OPENTitle: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049192Best OA location URL: https://journals.biologists.com/dmm/article-pdf/15/6/dmm049192/2145803/dmm049192.pdfCitation Count: 11
-
OPENTitle: Comparative analysis of methods to reduce activation signature gene expression in PBMCsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-49611-2Best OA location URL: https://www.nature.com/articles/s41598-023-49611-2.pdfCitation Count: 6
-
RESTRICTEDTitle: Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohortJournal Name: eBioMedicinePublisher: Elsevier BVVol: 119Issue #:Start Page: 105866End Page: 105866Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105866Best OA location URL: https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(25)00310-X.pdfCitation Count: 0
-
OPENTitle: Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effectsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-34732-5Best OA location URL: https://www.nature.com/articles/s41467-022-34732-5.pdfCitation Count: 56
-
OPENTitle: T-cell based immunotherapies for Parkinson’s diseaseJournal Name: Exploration of Neuroprotective TherapyPublisher: Open Exploration PublishingVol: 1Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.37349/ent.2021.00007Best OA location URL: https://www.explorationpub.com/uploads/Article/A10047/10047.pdfCitation Count: 11
- Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition2019OPENTitle: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competitionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104577End Page: 104577Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104577Citation Count: 41
-
OPENTitle: Forward and backward walking share the same motor modules and locomotor adaptation strategiesJournal Name: HeliyonPublisher: Elsevier BVVol: 7Issue #: 8Start Page: e07864End Page: e07864Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.heliyon.2021.e07864Best OA location URL: http://www.cell.com/article/S2405844021019678/pdfCitation Count: 14
-
OPENTitle: Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodiesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 10Start Page: 769End Page: 780Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.337Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.337Citation Count: 60
-
OPENTitle: Altered Differentiation Potential of Gaucher’s Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin DownregulationJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 9Issue #: 6Start Page: 1853End Page: 1867Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2017.10.029Best OA location URL: http://www.cell.com/article/S2213671117304848/pdfCitation Count: 47
-
OPENTitle: Alpha-synuclein abundance and localization are regulated by the RNA-binding protein PUMILIO1Journal Name: Cell ReportsPublisher: Elsevier BVVol: 44Issue #: 8Start Page: 116145End Page: 116145Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.celrep.2025.116145Best OA location URL: https://doi.org/10.1016/j.celrep.2025.116145Citation Count: 1
-
OPENTitle: An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson’s Disease Risk and Progression in the PPMI CohortJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 21Issue #: 18Start Page: 6562End Page: 6562Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms21186562Best OA location URL: https://www.mdpi.com/1422-0067/21/18/6562/pdfCitation Count: 33
-
OPENTitle: Disruption of the LRRK2‐FADD Interface Using Constrained PeptidesJournal Name: Peptide SciencePublisher: WileyVol: 116Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/pep2.24374Best OA location URL: https://doi.org/10.1002/pep2.24374Citation Count: 0
-
OPENTitle: Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 203Issue #: 2Start Page: 512End Page: 520Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2006.09.004Best OA location URL: http://doi.org/10.1016/j.expneurol.2006.09.004Citation Count: 97
-
RESTRICTEDTitle: 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease modelJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 60Issue #:Start Page: 108End Page: 114Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.08.014Best OA location URL: https://doaj.org/article/65cb9c949d0049cbaa552f3b16529335Citation Count: 52
-
RESTRICTEDTitle: The link between mitochondrial complex I and brain-derived neurotrophic factor in SH-SY5Y cells – The potential of JNX1001 as a therapeutic agentJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 764Issue #:Start Page: 379End Page: 384Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2015.07.013Citation Count: 20
-
OPENTitle: Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitorsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 473Issue #: 17Start Page: 2671End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20160557Best OA location URL: https://portlandpress.com/biochemj/article-pdf/473/17/2671/687564/bj4732671.pdfCitation Count: 170
-
OPENTitle: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSFJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0130-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0130-3Citation Count: 21
-
RESTRICTEDTitle: Carepartner Communication on Parkinson Disease Psychosis (4116)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4116Citation Count: 0
-
OPENTitle: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathyJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 82Issue #: 6Start Page: 457End Page: 466Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlad026Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10209646/pdf/nlad026.pdfCitation Count: 13
-
OPENTitle: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3865178Citation Count: 63
-
OPENTitle: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 919End Page: 927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26170Best OA location URL: http://doi.org/10.1002/mds.26170Citation Count: 282
- A dual-functional substrate for quantitation of substrate levels and GCase activity in living cells2025OPENTitle: A dual-functional substrate for quantitation of substrate levels and GCase activity in living cellsJournal Name: RSC Chemical BiologyPublisher: Royal Society of Chemistry (RSC)Vol: 6Issue #: 8Start Page: 1297End Page: 1305Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d5cb00045aBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2025/cb/d5cb00045aCitation Count: 2
-
OPENTitle: Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal ControlsJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 20Issue #: 9Start Page: 4303End Page: 4317Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.1c00290Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11060066Citation Count: 44
- Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium2011OPENTitle: Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortiumJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 307Issue #: 1-2Start Page: 22End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.031Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3155471Citation Count: 56
-
OPENTitle: The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregationJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01256-wBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01256-wCitation Count: 11
-
OPENTitle: Alzheimer's disease: Pathogenesis and preventionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 3Start Page: 227End Page: 233Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2012.01.011Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2012.01.011Citation Count: 97
-
OPENTitle: Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue HomogenatesJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 4Start Page: 824End Page: 829Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.9b01044Citation Count: 10
-
RESTRICTEDTitle: Neuropsychological impairment in prodromal Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 371Issue #:Start Page: 117End Page: 120Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2016.10.007Citation Count: 14
-
OPENTitle: Amnestic mild cognitive impairment individuals with dissimilar pathologic origins show common regional vulnerability in the default mode networkJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 10Issue #: 1Start Page: 717End Page: 725Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2018.08.004Best OA location URL: https://doi.org/10.1016/j.dadm.2018.08.004Citation Count: 6